These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33805390)

  • 1. Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review.
    Bedei I; Wolter A; Weber A; Signore F; Axt-Fliedner R
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33805390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined first-trimester screening and invasive diagnostics for atypical chromosomal aberrations: Danish nationwide study of prenatal profiles and detection compared with NIPT.
    Gadsbøll K; Vogel I; Kristensen SE; Pedersen LH; Hyett J; Petersen OB;
    Ultrasound Obstet Gynecol; 2024 Oct; 64(4):470-479. PubMed ID: 38642365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
    Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
    Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a Paired-End Sequencing-Based Noninvasive Prenatal Screening Test in the Detection of Genome-Wide Fetal Chromosomal Anomalies.
    Pertile MD; Flowers N; Vavrek D; Andrews D; Kalista T; Craig A; Deciu C; Duenwald S; Meier K; Bhatt S
    Clin Chem; 2021 Sep; 67(9):1210-1219. PubMed ID: 34077512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.
    Beulen L; Faas BHW; Feenstra I; van Vugt JMG; Bekker MN
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):721-728. PubMed ID: 27515011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome non-invasive prenatal testing in prenatal screening algorithm: clinical experience from 12,700 pregnancies.
    Baranova EE; Sagaydak OV; Galaktionova AM; Kuznetsova ES; Kaplanova MT; Makarova MV; Belenikin MS; Olenev AS; Songolova EN
    BMC Pregnancy Childbirth; 2022 Aug; 22(1):633. PubMed ID: 35945516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of SNP-based chromosomal microarray and NIPT on the diagnostic yield in 10,000 fetuses with and without fetal ultrasound anomalies.
    Srebniak MI; Knapen MFCM; Polak M; Joosten M; Diderich KEM; Govaerts LCP; Boter M; Kromosoeto JNR; van Hassel DACM; Huijbregts G; van IJcken WFJ; Heydanus R; Dijkman A; Toolenaar T; de Vries FAT; Knijnenburg J; Go ATJI; Galjaard RH; Van Opstal D
    Hum Mutat; 2017 Jul; 38(7):880-888. PubMed ID: 28409863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis.
    Stosic M; Levy B; Wapner R
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):55-68. PubMed ID: 29428286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
    Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
    BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities.
    Fiorentino F; Napoletano S; Caiazzo F; Sessa M; Bono S; Spizzichino L; Gordon A; Nuccitelli A; Rizzo G; Baldi M
    Eur J Hum Genet; 2013 Jul; 21(7):725-30. PubMed ID: 23211699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive prenatal testing for aneuploidy: current status and future prospects.
    Benn P; Cuckle H; Pergament E
    Ultrasound Obstet Gynecol; 2013 Jul; 42(1):15-33. PubMed ID: 23765643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.